AAAAAA

   
Results: 1-17 |
Results: 17
Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis
Authors: Zcharia, E Metzger, S Chajek-Shaul, T Friedmann, Y Pappo, O Aviv, A Elkin, M Pecker, I Peretz, T Vlodavsky, I
Citation: E. Zcharia et al., Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis, J MAMMARY G, 6(3), 2001, pp. 311-322
A deletion/insertion mutation in the BRCA2 gene in a breast cancer family:A possible role of the Alu-polyA tail in the evolution of the deletion
Authors: Wang, T Lerer, I Gueta, Z Sagi, M Kadouri, L Peretz, T Abeliovich, D
Citation: T. Wang et al., A deletion/insertion mutation in the BRCA2 gene in a breast cancer family:A possible role of the Alu-polyA tail in the evolution of the deletion, GENE CHROM, 31(1), 2001, pp. 91-95
Determinants of the use of complementary therapies by patients with cancer
Authors: Paltiel, O Avitzour, M Peretz, T Cherny, N Kaduri, L Pfeffer, RM Wagner, N Soskolne, V
Citation: O. Paltiel et al., Determinants of the use of complementary therapies by patients with cancer, J CL ONCOL, 19(9), 2001, pp. 2439-2448
The use of external radioactive markers in scintimammography
Authors: Klein, M Weininger, J Moshe, S Peretz, T Chisin, R
Citation: M. Klein et al., The use of external radioactive markers in scintimammography, CLIN NUCL M, 26(1), 2001, pp. 10-13
Psychological intervention in cancer patients: a randomized study
Authors: Baider, L Peretz, T Hadani, PE Koch, U
Citation: L. Baider et al., Psychological intervention in cancer patients: a randomized study, GEN HOSP PS, 23(5), 2001, pp. 272-277
CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers
Authors: Kadouri, L Easton, DF Edwards, S Hubert, A Kote-Jarai, Z Glaser, B Durocher, F Abeliovich, D Peretz, T Eeles, RA
Citation: L. Kadouri et al., CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers, BR J CANC, 85(1), 2001, pp. 36-40
Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadianand Yemenite Jewish hereditary breast cancer families
Authors: Manning, AP Abelovich, D Ghadirian, P Lambert, JA Frappier, D Provencher, D Robidoux, A Peretz, T Narod, SA Mes-Masson, AM Foulkes, WD Wang, TL Morgan, K Fujiwara, TM Tonin, PN
Citation: Ap. Manning et al., Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadianand Yemenite Jewish hereditary breast cancer families, HUMAN HERED, 52(2), 2001, pp. 116-120
Prognostic efficacy of TPS in breast cancer
Authors: Barak, V Nisman, B Hubert, A Lyass, O Kaduri, L Peretz, T
Citation: V. Barak et al., Prognostic efficacy of TPS in breast cancer, J TUMOR M, 15(3), 2000, pp. 171-176
Bone marrow metastases in breast cancer
Authors: Pikarsky, E Peretz, T
Citation: E. Pikarsky et T. Peretz, Bone marrow metastases in breast cancer, N ENG J MED, 343(8), 2000, pp. 577-578
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin
Authors: Lotem, M Hubert, A Lyass, O Goldenhersh, MA Ingber, A Peretz, T Gabizon, A
Citation: M. Lotem et al., Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin, ARCH DERMAT, 136(12), 2000, pp. 1475-1480
Transmission of response to trauma? Second-generation Holocaust survivors'reaction to cancer
Authors: Baider, L Peretz, T Hadani, PE Perry, S Avramov, R De-Nour, AK
Citation: L. Baider et al., Transmission of response to trauma? Second-generation Holocaust survivors'reaction to cancer, AM J PSYCHI, 157(6), 2000, pp. 904-910
Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma - Evidence for its role in colonic tumorigenesis
Authors: Friedmann, Y Vlodavsky, I Aingorn, H Aviv, A Peretz, T Pecker, I Pappo, O
Citation: Y. Friedmann et al., Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma - Evidence for its role in colonic tumorigenesis, AM J PATH, 157(4), 2000, pp. 1167-1175
Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
Authors: Vlodavsky, I Friedmann, Y Elkin, M Aingorn, H Atzmon, R Ishai-Michaeli, R Bitan, M Pappo, O Peretz, T Michal, I Spector, L Pecker, I
Citation: I. Vlodavsky et al., Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis, NAT MED, 5(7), 1999, pp. 793-802
Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers
Authors: Kaduri, L Gibs, M Hubert, A Sagi, M Heching, N Lerer, I Uziely, B Weinberg, N Abeliovich, D Peretz, T
Citation: L. Kaduri et al., Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers, EUR J OB GY, 85(1), 1999, pp. 75-80
Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer
Authors: Nisman, B Amir, G Lafair, J Heching, N Lyass, O Peretz, T Barak, V
Citation: B. Nisman et al., Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer, ANTICANC R, 19(4C), 1999, pp. 3549-3552
The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer
Authors: Hubert, A Peretz, T Manor, O Kaduri, L Wienberg, N Lerer, I Sagi, M Abeliovich, D
Citation: A. Hubert et al., The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer, AM J HU GEN, 65(3), 1999, pp. 921-924
Changes in cytokine production of breast cancer patients treated with interferons
Authors: Barak, V Kalickman, I Nisman, B Farbstein, H Fridlender, ZG Baider, L Kaplan, A Stephanos, S Peretz, T
Citation: V. Barak et al., Changes in cytokine production of breast cancer patients treated with interferons, CYTOKINE, 10(12), 1998, pp. 977-983
Risultati: 1-17 |